These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 13018069)
41. [Therapy of manic-depressive psychosis with aminazine]. NEVZOROVA TA Zh Nevropatol Psikhiatr Im S S Korsakova; 1959; 59():1215-21. PubMed ID: 14426768 [No Abstract] [Full Text] [Related]
42. [Combined therapy of severe manic and manic-like irritable states with Megaphen-Randolectil. (Preliminary report)]. BRYK B; MOLDENHAUE RB Med Welt; 1962 Jun; 25():1426-7. PubMed ID: 13874147 [No Abstract] [Full Text] [Related]
43. [Manic-depressive psychoses and vitamin D2 therapy in shock doses; biochemistry and therapeutic results]. BONELLI C Rass Neuropsichiatr; 1952; 6(4):277-88. PubMed ID: 13014366 [No Abstract] [Full Text] [Related]
44. [The use of chlorprothixen (RO 4-0403) in manic-depressive psychosis]. MADALENA JC Hospital (Rio J); 1962 Feb; 61():381-2. PubMed ID: 14468084 [No Abstract] [Full Text] [Related]
45. [Effectiveness and mechanism of action of lithium salts in manic-depressive psychoses]. Rapisarda V; Raffaele R Osp Psichiatr; 1970; 38(4):565-71. PubMed ID: 5526811 [No Abstract] [Full Text] [Related]
46. [Pharmacotherapy of manic-depressive psychoses (role of lithium salts in therapy and prophylaxis]. Mihovilović M; Bohacek N Neuropsihijatrija; 1969; 17(34):63-73. PubMed ID: 5200798 [No Abstract] [Full Text] [Related]
47. [Treatment of depressive states with iprazid]. MOROZOVA TN Zh Nevropatol Psikhiatr Im S S Korsakova; 1959; 59():1480-4. PubMed ID: 14424282 [No Abstract] [Full Text] [Related]
48. [Treatment of depressive states with lithium salts and its importance for the understanding of manic-depressive psychosis]. Pogadi I; Vidermann V Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(8):1207-8. PubMed ID: 899532 [TBL] [Abstract][Full Text] [Related]
49. Evaluation of lithium in treatment of psychotic excitement. GLESINGER B Med J Aust; 1954 Feb; 41(1 8):277-83. PubMed ID: 13153553 [No Abstract] [Full Text] [Related]
50. [TREATMENT OF MANIC PATIENTS WITH CHLORPROTHIXENE (TRUXAL) IN COMPARISON WITH OTHER TREATMENT METHODS, WITH SPECIAL REFERENCE TO THE DURATION OF STABILIZATION]. Ravn J; Kragh ER Acta Psychiatr Scand; 1963; 38(s169):139-51. PubMed ID: 14085189 [No Abstract] [Full Text] [Related]
52. [Therapy of depressive states with iprazid]. DOBRZHANSKAIA AK Zh Nevropatol Psikhiatr Im S S Korsakova; 1959; 59():1485-8. PubMed ID: 13817092 [No Abstract] [Full Text] [Related]
53. An intensive study of twelve cases of manic-depressive psychosis. COHEN MB; BAKER G; COHEN RA; FROMM-REICHMANN F; WEIGERT EV Psychiatry; 1954 May; 17(2):103-37. PubMed ID: 13167224 [No Abstract] [Full Text] [Related]
54. [Lithium in therapy of manic psychoses]. SCHOU M; JUEL-NIELSEN N; STROMGREN E; VOLDBY H Ugeskr Laeger; 1955 Jan; 117(4):93-101. PubMed ID: 14374037 [No Abstract] [Full Text] [Related]
55. The effect of reserpine on the duration of manic attacks. WATT DC J Neurol Neurosurg Psychiatry; 1958 Nov; 21(4):297-300. PubMed ID: 13611572 [No Abstract] [Full Text] [Related]
56. [On the therapy of manic-depressive psychoses with lithium salts]. Gonzales R; Lauter H Nervenarzt; 1968 Jan; 39(1):11-6. PubMed ID: 5652186 [No Abstract] [Full Text] [Related]
57. [Emotional shock; therapeutic effects; first biological data]. DELAY J; LAINE B; PUECH J; CIAVREUL J Ann Med Psychol (Paris); 1952 Apr; 110(1 4):476-80. PubMed ID: 14944028 [No Abstract] [Full Text] [Related]
59. [OUR EXPERIENCES WITH A NEW MAJOR NEUROLEPTIC: HALOPERIDOL]. GALINDEZ L; SANTOS MR; BOREL RO Dia Med; 1963 Sep; 35():1435-6. PubMed ID: 14088362 [No Abstract] [Full Text] [Related]
60. [Clinical results of treatment with "IIH" in cases of essential and symptomatic depressive psychopathy and psychoses]. BELUFFI M Gazz Med Ital; 1959 Aug; 118():307-14. PubMed ID: 13798674 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]